Who owns the XSATE GLYPHOSATE 41% trademark?

The XSATE GLYPHOSATE 41% trademark is owned by Xingfa USA Corporation.

What class is the XSATE GLYPHOSATE 41% trademark registered in?

The XSATE GLYPHOSATE 41% trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for XSATE GLYPHOSATE 41%?

The USPTO serial number for XSATE GLYPHOSATE 41% is 97263181.

What is the registration number for XSATE GLYPHOSATE 41%?

XSATE GLYPHOSATE 41% is registered under USPTO registration number 7680818.

XSA

USPTO Trademark Record

REGISTERED

XSATE GLYPHOSATE 41%

SN 97263181·Reg 7680818·Filed Feb 11, 2022

Owner Xingfa USA Corporation

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

XSATE GLYPHOSATE 41% (Serial No. 97263181), Registration No. 7680818, is a registered US trademark filed on Feb 11, 2022 by Xingfa USA Corporation. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

early section 8: February 04, 2031

Mark Intelligence

XSATE GLYPHOSATE 41% (Reg. #7680818) is a registered US trademark that has been protecting its owner, Xingfa USA Corporation, since 2022. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Feb 11, 2022

SERIAL

97263181

REG#

7680818

REGISTERED

Feb 04, 2025

Owner

Applicant

Xingfa USA Corporation

Entity

Corporation

State

Address

16200 Park Row Dr., Suite 195, Houston, TX, 77084

Country

Attorney

NameJerry Carleton

Law firm

Jerry Carleton IMMIX LAW GROUP PC

Address

600 NW NAITO PKWY, SUITE G, PORTLAND, OR 97209, United States

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateFeb 11, 2022

Serial Number97263181

Registration No.7680818

Registration DateFeb 04, 2025

Status DateFeb 04, 2025

Published for OppositionMar 14, 2023

Mark TypeStandard characters

Status DescriptionLive and registered

Filing Signals

FILED

2022

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

First use anywhere: Aug 15, 2024

First use in commerce: Aug 15, 2024

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

32 events

REGISTERED-PRINCIPAL REGISTER

Feb 04, 2025

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Feb 04, 2025

NOTICE OF REGISTRATION CONFIRMATION EMAILED

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Jan 10, 2025

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Jan 10, 2025

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

SOU TEAS EXTENSION RECEIVED

Nov 08, 2024

SOU TEAS EXTENSION RECEIVED

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Oct 30, 2024

CASE ASSIGNED TO INTENT TO USE PARALEGAL

STATEMENT OF USE PROCESSING COMPLETE

Oct 30, 2024

STATEMENT OF USE PROCESSING COMPLETE

USE AMENDMENT FILED

Aug 28, 2024

USE AMENDMENT FILED

TEAS STATEMENT OF USE RECEIVED

Aug 28, 2024

TEAS STATEMENT OF USE RECEIVED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Apr 13, 2024

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

Apr 12, 2024

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 2 FILED

Apr 12, 2024

SOU EXTENSION 2 FILED

SOU EXTENSION 2 GRANTED

Apr 12, 2024

SOU EXTENSION 2 GRANTED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Nov 08, 2023

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU EXTENSION 1 FILED

Nov 06, 2023

SOU EXTENSION 1 FILED

SOU EXTENSION 1 GRANTED

Nov 06, 2023

SOU EXTENSION 1 GRANTED

SOU TEAS EXTENSION RECEIVED

Nov 06, 2023

SOU TEAS EXTENSION RECEIVED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

May 09, 2023

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Mar 14, 2023

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Mar 14, 2023

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Feb 22, 2023

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

EXAMINERS AMENDMENT -WRITTEN

Feb 09, 2023

EXAMINERS AMENDMENT -WRITTEN

EXAMINERS AMENDMENT E-MAILED

Feb 09, 2023

EXAMINERS AMENDMENT E-MAILED

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Feb 09, 2023

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

EXAMINER'S AMENDMENT ENTERED

Feb 09, 2023

EXAMINER'S AMENDMENT ENTERED

APPROVED FOR PUB - PRINCIPAL REGISTER

Feb 09, 2023

APPROVED FOR PUB - PRINCIPAL REGISTER

NON-FINAL ACTION WRITTEN

Dec 07, 2022

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Dec 07, 2022

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Dec 07, 2022

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

Nov 28, 2022

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Feb 16, 2022

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Feb 15, 2022

NEW APPLICATION ENTERED

XSATE GLYPHOSATE 41%

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by Xingfa USA Corporation

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by Jerry Carleton

Resources

Company